RelayHealth
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $3.9m | Series B | |
$19.0m | Series C | ||
N/A | $13.1m | Series D | |
$6.3m | Series E | ||
N/A | $10.0m | Series F | |
$7.0m | Series G | ||
N/A | N/A | Acquisition | |
Total Funding | $59.3m |
Recent News about RelayHealth
EditRelayHealth, a subsidiary of McKesson Corporation, operates in the healthcare sector, providing a range of services aimed at improving patient care and operational efficiency for healthcare providers, pharmacies, and biopharma companies. The company offers accurate and safe drug distribution services, ensuring timely delivery and adherence to medication protocols. RelayHealth also provides pharmacy management tools and consultancy services to help independent pharmacies build healthier businesses and support patient health more effectively. Additionally, the company supports specialty practices, such as oncology, with top-of-the-line Electronic Health Records (EHR) systems and group purchasing solutions. RelayHealth's business model revolves around offering value-based care programs and commercialization services, which help bring groundbreaking treatments to patients who need them most. The company generates revenue through the sale of medical supplies, pharmaceuticals, and healthcare solutions, as well as through consultancy and management services. RelayHealth serves a diverse client base, including hospitals, medical practices, pharmacies, and biopharma companies, operating primarily in the North American market.
Keywords: healthcare solutions, drug distribution, pharmacy management, specialty services, EHR systems, value-based care, commercialization, medical supplies, biopharma, North America.